Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Cai

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Hypotheses|May 1, 1995
Tumorigenesis and cell evolutionD W Cai
Cancer Gene Therapy|September 1, 1995
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNAD W Cai, T Mukhopadhyay, J A Roth
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|April 1, 1994
[c-myc gene and p53 protein expression in human primary liver carcinoma]D W Cai, C Z Gao, N J Wang
Human Gene Therapy|October 1, 1993
Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transferD W Cai, T Mukhopadhyay, Y Liu, et al.
International Journal of Cancer|March 15, 1994
Retroviral-mediated transduction of p53 gene increases TGF-beta expression in a human glioblastoma cell lineT Fujiwara, T Mukhopadhyay, D W Cai, et al.
Journal of the National Cancer Institute|October 5, 1994
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer modelT Fujiwara, D W Cai, R N Georges, et al.
Cancer Research|September 15, 1993
A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosisT Fujiwara, E A Grimm, T Mukhopadhyay, et al.
The Journal of International Medical Research|February 12, 2010
Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese populationD W Cai, X F Liu, R G Bu, et al.
Human Cell|March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]T Fujiwara, S Kagawa, N Ogawa, et al.
European Review for Medical and Pharmacological Sciences|May 18, 2018
Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathwayD-W Cai, D Chen, S-P Sun, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Hypotheses|May 1, 1995
Tumorigenesis and cell evolutionD W Cai
Cancer Gene Therapy|September 1, 1995
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNAD W Cai, T Mukhopadhyay, J A Roth
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|April 1, 1994
[c-myc gene and p53 protein expression in human primary liver carcinoma]D W Cai, C Z Gao, N J Wang
Human Gene Therapy|October 1, 1993
Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transferD W Cai, T Mukhopadhyay, Y Liu, et al.
International Journal of Cancer|March 15, 1994
Retroviral-mediated transduction of p53 gene increases TGF-beta expression in a human glioblastoma cell lineT Fujiwara, T Mukhopadhyay, D W Cai, et al.
Journal of the National Cancer Institute|October 5, 1994
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer modelT Fujiwara, D W Cai, R N Georges, et al.
Cancer Research|September 15, 1993
A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosisT Fujiwara, E A Grimm, T Mukhopadhyay, et al.
The Journal of International Medical Research|February 12, 2010
Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese populationD W Cai, X F Liu, R G Bu, et al.
Human Cell|March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]T Fujiwara, S Kagawa, N Ogawa, et al.
European Review for Medical and Pharmacological Sciences|May 18, 2018
Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathwayD-W Cai, D Chen, S-P Sun, et al.
Pageof 2